ULIPRISTAL ACETATE (Esmya ®)
Clinical Indication
Uterine fibroids
Comments
In line with MHRA alert March 2020 regarding risks of liver injury.
Date of classification
February 2019
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.